Padlock Therapeutics Director of Finance Salaries in Providence, RI | Comparably
Padlock is developing medicines targeting PADs, immune complexes in autoimmune diseases, and more. read more
EMPLOYEE
PARTICIPANTS
3
TOTAL
RATINGS
95

Padlock Therapeutics Director of Finance Salaries in Providence, RI

The average Padlock Therapeutics Director of Finance in Providence, RI earns an estimated $146,672 annually. Padlock Therapeutics' Director of Finance compensation is $15,344 less than the US average for a Director of Finance.

In Providence, RI, The Finance Department at Padlock Therapeutics earns $18,288 more on average than the Customer Support Department.

Last updated 5 years ago.

$30k
$74k
$117k
$159k
$350k
$600k
$146,672
Average Compensation
$146,672
avg. base

Director of Finance Salaries at Padlock Therapeutics

In Providence, RI, Directors of Finance earn $25,743 more than Accounting Managers.

Accounting Manager
$121k*
Senior Accountant
$92k*
Business Analyst
$89k*
Financial Analyst
$86k*
Accountant
$71k*
* estimated salary

Compensation at Padlock Therapeutics by Department

In Providence, RI, The Finance Department averages $18,288 more than the Customer Support Department, and $9,307 less than the Operations Department

Operations
$91,323 Avg. total comp.
+$9k
Finance
$82,016 Avg. total comp.
Customer Support
$63,728 Avg. total comp.
-$18k

Director of Finance Compensation by Gender (All Companies)

The average female Director of Finance at companies similar size to Padlock Therapeutics reported making $176,135, while the average male Director of Finance at similar sized companies reported making $188,131.

Director of Finance Compensation by Ethnicity (All Companies)

The average Asian or Pacific Islander Director of Finance at companies similar size to Padlock Therapeutics reported making $193,239, while the average Native American Director of Finance at similar sized companies reported making $145,000.

How Directors of Finance at Padlock Therapeutics Rate Their Compensation

The majority of Directors of Finance at Padlock Therapeutics believe they're compensated fairly. 50% of Directors of Finance at Padlock Therapeutics say they receive annual bonuses, and the vast majority (100%) are satisfied with their benefits. See more compensation ratings at Padlock Therapeutics

×
Rate your company